We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Over Thirty Nucleic Acid-Based Diagnostic Kits Released

By LabMedica International staff writers
Posted on 01 Apr 2010
More than 30 new kits were launched for nucleic acid (NA)-based diagnostics.

The new basket of diagnostic kits includes kits for the diagnosis of human pathogens such as human papillomavirus (HPV), human immunodeficiency virus (HIV), hepatitis C virus (HCV)-1 and 2, hepatitis B virus (HBV), Chlamydia, and Neisseria gonorrhea. More...
These kits were designed for noninvasive sample preparation. Other kits were developed for food-borne pathogens and plant pathogens.

The complete kits include all the components for the isolation of high quality inhibitor-free nucleic acids, as well as the required master mixes and controls to allow for polymerase chain reaction (PCR) amplification and detection. The kits combine both sensitivity and specificity of detection, and include controls to eliminate false negatives and problematic isolations.

Noninvasive sample collection offers a number of distinct benefits for diagnostics, therefore Norgen Biotek first plans to obtain regulatory approval for the urine-based pathogen detection kits. These pathogens are traditionally detected in blood or plasma. The kits are produced by Norgen Biotek Corp. (Thorold, Canada) a privately owned biotechnology company that focuses primarily on advancing tools for nucleic acids (NAs) and protein purification.

"The transition of our powerful nucleic acid isolation technology into diagnostics is a natural extension for us. The quality of a diagnostic kit is only as good as the quality of the sample, and as leaders in sample preparation we are in an ideal position to make this transition," said Dr. Haj-Ahmad, president and CEO of Norgen Biotek. "These kits will become invaluable tools for noninvasive urine-based diagnostics," he added.

Meanwhile, the kits are ideal for use in surveillance of drug resistant pathogens, epidemiological studies, field surveillance of pathogens, and surveys.

Norgen Biotek Corp. provides its customers with sample preparation kits for RNA, microRNA, DNA, and protein purification, cleanup and concentration, as well as support services to customers and partners worldwide.

Related Links:
Norgen Biotek Corp.



New
Gold Member
Collection and Transport System
PurSafe Plus®
Portable Electronic Pipette
Mini 96
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.